Anheuser-Busch InBev SA/NV (1NBA.DE)
EUR 48.92
(-1.35%)
EUR 48.92
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 13.26 Billion | 13.29 Billion | 14.79 Billion | 14.03 Billion | 13.39 Billion | 14.66 Billion |
| Net Income | 6.89 Billion | 7.59 Billion | 6.11 Billion | 9.99 Billion | 9.99 Billion | 5.69 Billion |
| Depreciation & Amortization | 5.41 Billion | 5.07 Billion | 5.05 Billion | 4.82 Billion | 4.65 Billion | 4.26 Billion |
| Deferred income taxes | 2.23 Billion | 1.92 Billion | 2.35 Billion | 1.93 Billion | 2.78 Billion | 2.83 Billion |
| Stock-based compensation | 570 Million | 448 Million | 510 Million | 169 Million | 340 Million | 337 Million |
| Change in working capital | -1.54 Billion | -346 Million | 2.45 Billion | -5 Million | -5 Million | 512 Million |
| Other non-cash items | -301 Million | -1.4 Billion | -1.68 Billion | -2.87 Billion | -4.37 Billion | 1.02 Billion |
| Investing Cash Flow | -4.35 Billion | -4.62 Billion | -5.87 Billion | -4.93 Billion | -5.07 Billion | -3.96 Billion |
| Investments in PPE | -4.63 Billion | -5.16 Billion | -5.64 Billion | -4.85 Billion | -5.17 Billion | -5.08 Billion |
| Acquisitions | 9 Million | -70 Million | -444 Million | -33 Million | -252 Million | -185 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 275 Million | 610 Million | 206 Million | -44 Million | 353 Million | 1.3 Billion |
| Financing Cash Flow | -8.59 Billion | -10.62 Billion | -11.59 Billion | -8.75 Billion | -8.51 Billion | -13.94 Billion |
| Debt repayment | -3.87 Billion | -7.87 Billion | -9.49 Billion | -441 Million | -31.03 Billion | -22.48 Billion |
| Dividends payments | -3.01 Billion | -2.44 Billion | -2.36 Billion | -1.8 Billion | -5.01 Billion | -7.76 Billion |
| Common Stock Repurchased | -362 Million | - | - | -8.03 Billion | 22.58 Billion | - |
| Common Stock Issuance | 202 Million | - | - | 5.57 Billion | 5.57 Billion | - |
| Other Financing Activities | -1.54 Billion | -303 Million | 262 Million | -842 Million | -623 Million | 16.3 Billion |
| Accounts receivables | -1.14 Billion | -48 Million | 164 Million | 516 Million | -258 Million | -105 Million |
| Accounts payables | - | 48 Million | -164 Million | -516 Million | 258 Million | - |
| Inventory | 717 Million | -1.54 Billion | -1.23 Billion | -427 Million | -426 Million | -603 Million |
| Other working capital | -2.25 Billion | 1.2 Billion | 3.69 Billion | 422 Million | 421 Million | 1.11 Billion |
| Cash at beginning of period | 9.89 Billion | 12.04 Billion | 15.24 Billion | 7.16 Billion | 6.96 Billion | 10.35 Billion |
| Cash at end of period | 10.31 Billion | 9.89 Billion | 12.04 Billion | 15.24 Billion | 7.16 Billion | 6.96 Billion |
| Capital Expenditure | -4.63 Billion | -5.16 Billion | -5.64 Billion | -4.85 Billion | -5.17 Billion | -5.08 Billion |
| Effect of forex changes on cash | 109 Million | -211 Million | -526 Million | -674 Million | -141 Million | -148 Million |
| Net cash flow / Change in cash | 424 Million | -2.15 Billion | -3.2 Billion | 8.07 Billion | 209 Million | -3.39 Billion |
| Free Cash Flow | 8.62 Billion | 8.13 Billion | 9.15 Billion | 9.18 Billion | 8.22 Billion | 9.57 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.47 Billion | 1.09 Billion | 1.89 Billion | 6.89 Billion | 1.47 Billion | 338 Million |
| Depreciation & Amortization | - | - | - | 5.41 Billion | - | - |
| Deferred income taxes | - | - | - | 2.23 Billion | - | - |
| Stock-based compensation | 315 Million | - | 570 Million | 570 Million | - | 286 Million |
| Change in working capital | - | - | - | -1.54 Billion | - | - |
| Other non-cash items | -1.78 Billion | -1.09 Billion | -2.46 Billion | -301 Million | -1.47 Billion | -624 Million |
| Investing Cash Flow | - | - | - | -4.35 Billion | - | - |
| Investments in PPE | - | - | - | -4.63 Billion | - | - |
| Acquisitions | - | - | - | 9 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 275 Million | - | - |
| Financing Cash Flow | - | - | - | -8.59 Billion | - | - |
| Debt repayment | - | - | - | -3.87 Billion | - | - |
| Dividends payments | - | - | - | -3.01 Billion | - | - |
| Common Stock Repurchased | - | - | - | -362 Million | - | - |
| Common Stock Issuance | - | - | - | 202 Million | - | - |
| Other Financing Activities | - | - | - | -1.54 Billion | - | - |
| Accounts receivables | - | - | - | -1.14 Billion | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | 717 Million | - | - |
| Other working capital | - | - | - | -2.25 Billion | - | - |
| Cash at beginning of period | - | - | - | 9.89 Billion | - | - |
| Cash at end of period | - | - | - | 10.31 Billion | - | 286 Million |
| Capital Expenditure | - | - | - | -4.63 Billion | - | - |
| Effect of forex changes on cash | - | - | - | 109 Million | - | - |
| Net cash flow / Change in cash | - | - | - | 424 Million | - | 286 Million |
| Free Cash Flow | - | - | - | 8.62 Billion | - | 286 Million |
AXCP
BAJAJHIND
COSCO
JOHNPHARMA
GML
2125